ArticleBritish journal of clinical pharmacology2022
Pharmacometric analyses and clinical evidence for brigatinib dosing in anaplastic lymphoma kinase-positive non-small cell lung cancer.
Neeraj Gupta et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.